Liquidia Corp. (LQDA)
42.65
+2.96
(+7.46%)
USD |
NASDAQ |
Oct 23, 16:00
42.25
-0.40
(-0.94%)
After-Hours: 20:00
Liquidia Price to Book Value : 19.48 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 19.48 |
| October 22, 2026 | 18.12 |
| October 21, 2026 | 17.75 |
| October 20, 2026 | 16.60 |
| October 19, 2026 | 15.59 |
| October 16, 2026 | 15.69 |
| October 15, 2026 | 15.88 |
| October 14, 2026 | 15.50 |
| October 13, 2026 | 12.24 |
| October 12, 2026 | 12.64 |
| October 09, 2026 | 12.50 |
| October 08, 2026 | 12.80 |
| October 07, 2026 | 12.18 |
| October 06, 2026 | 11.83 |
| October 05, 2026 | 12.62 |
| October 02, 2026 | 13.08 |
| October 01, 2026 | 12.78 |
| September 30, 2026 | 13.82 |
| September 29, 2026 | 32.28 |
| September 28, 2026 | 33.64 |
| September 25, 2026 | 31.25 |
| September 24, 2026 | 32.40 |
| September 23, 2026 | 30.82 |
| September 22, 2026 | 31.34 |
| September 21, 2026 | 30.34 |
| Date | Value |
|---|---|
| September 18, 2026 | 30.54 |
| September 17, 2026 | 31.23 |
| September 16, 2026 | 31.26 |
| September 15, 2026 | 30.01 |
| September 14, 2026 | 29.82 |
| September 11, 2026 | 30.48 |
| September 10, 2026 | 30.98 |
| September 09, 2026 | 31.56 |
| September 08, 2026 | 30.91 |
| September 04, 2026 | 31.35 |
| September 03, 2026 | 31.34 |
| September 02, 2026 | 31.82 |
| September 01, 2026 | 30.55 |
| August 31, 2026 | 31.13 |
| August 28, 2026 | 30.91 |
| August 27, 2026 | 31.94 |
| August 26, 2026 | 32.59 |
| August 25, 2026 | 32.19 |
| August 24, 2026 | 32.09 |
| August 21, 2026 | 31.34 |
| August 20, 2026 | 32.45 |
| August 19, 2026 | 34.40 |
| August 18, 2026 | 33.94 |
| August 17, 2026 | 35.48 |
| August 14, 2026 | 33.99 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Harmony Biosciences Holdings, Inc. | 2.102 |
| United Therapeutics Corp. | 3.917 |
| Johnson & Johnson | 7.789 |
| Amneal Pharmaceuticals, Inc. | 197.06 |
| Pfizer Inc. | 2.009 |
Price to Book Value Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 9.196 |
| Price to Free Cash Flow | 27.52 |
| Price | 42.65 |
| Earnings Yield | 3.20% |
| Market Cap | 3.800B |
| Operating PE Ratio | 24.60 |
| Normalized PE Ratio | 31.26 |